Pande Made Wisnu Tirtayasa, Gerhard Reinaldi Situmorang, Gede Wirya Kusuma Duarsa, Tanaya Ghinorawa, Etriyel Myh, Eriawan Agung Nugroho, Athaya Febriantyo Purnomo, Gede Wira Mahadita, Yenny Kandarini, Arry Rodjani, Nur Rasyid
{"title":"移植肾动脉狭窄的危险因素:荟萃分析。","authors":"Pande Made Wisnu Tirtayasa, Gerhard Reinaldi Situmorang, Gede Wirya Kusuma Duarsa, Tanaya Ghinorawa, Etriyel Myh, Eriawan Agung Nugroho, Athaya Febriantyo Purnomo, Gede Wira Mahadita, Yenny Kandarini, Arry Rodjani, Nur Rasyid","doi":"10.1016/j.transproceed.2025.08.017","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Transplant renal artery stenosis (TRAS) is a typical vascular complication that accounts for 75% of all vascular events following kidney transplantation. Post-transplant complications such as allograft dysfunction, allograft loss, and post-transplant hypertension have been attributed to TRAS. This study aims to evaluate the risk factors related to TRAS after kidney transplantation.</p><p><strong>Methods: </strong>A meta-analysis of studies that were published from inception until January 2024 was accomplished from the Science Direct and PubMed databases. Publications evaluating the prevalence of TRAS after kidney transplantation and assessing its risk factors were included in the study.</p><p><strong>Results: </strong>Sixteen publications were included in the study. The incidence of TRAS was 1465 cases (3.37%) from 43,446 patients. Several variables relating to the occurrence of TRAS after kidney transplantation were examined. The variables that related to the development of TRAS were multiple allograft arteries (OR 3.08 [95% CI 1.30-7.28], P = .01, I<sup>2</sup> = 33%), cold ischemia times (MD 4.40 [95% CI 3.72-5.08], P < .00001, I<sup>2</sup> = 0%), hypertension (RR 1.07 [1.03-1.11], P = .0006, I<sup>2</sup> = 0%), diabetes (RR 1.16 [1.04-1.29], P = .007, I<sup>2</sup> = 24%), ischemic heart disease (RR 1.51 [1.26-1.82], P < .00001, I<sup>2</sup> = 0%), systolic blood pressure (MD 10.98 [9.44-12.51], P < .00001, I<sup>2</sup> = 0%), diastolic blood pressure (MD 7.64 [2.30-12.97], P = .005, I<sup>2</sup> = 85%), delayed graft function (OR 2.11 [1.31-3.38], P = .002, I<sup>2</sup> = 58%), and acute rejection (RR 1.84 [1.24-2.71], P = .002, I<sup>2</sup> = 0%).</p><p><strong>Conclusions: </strong>Multiple variables have been identified as risk factors for TRAS. Since TRAS is linked to allograft dysfunction and poorer outcomes, effectively managing and improving these factors could result in better long-term results for kidney transplant recipients.</p>","PeriodicalId":94258,"journal":{"name":"Transplantation proceedings","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk Factors of Transplant Renal Artery Stenosis: A Meta-analysis.\",\"authors\":\"Pande Made Wisnu Tirtayasa, Gerhard Reinaldi Situmorang, Gede Wirya Kusuma Duarsa, Tanaya Ghinorawa, Etriyel Myh, Eriawan Agung Nugroho, Athaya Febriantyo Purnomo, Gede Wira Mahadita, Yenny Kandarini, Arry Rodjani, Nur Rasyid\",\"doi\":\"10.1016/j.transproceed.2025.08.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Transplant renal artery stenosis (TRAS) is a typical vascular complication that accounts for 75% of all vascular events following kidney transplantation. Post-transplant complications such as allograft dysfunction, allograft loss, and post-transplant hypertension have been attributed to TRAS. This study aims to evaluate the risk factors related to TRAS after kidney transplantation.</p><p><strong>Methods: </strong>A meta-analysis of studies that were published from inception until January 2024 was accomplished from the Science Direct and PubMed databases. Publications evaluating the prevalence of TRAS after kidney transplantation and assessing its risk factors were included in the study.</p><p><strong>Results: </strong>Sixteen publications were included in the study. The incidence of TRAS was 1465 cases (3.37%) from 43,446 patients. Several variables relating to the occurrence of TRAS after kidney transplantation were examined. The variables that related to the development of TRAS were multiple allograft arteries (OR 3.08 [95% CI 1.30-7.28], P = .01, I<sup>2</sup> = 33%), cold ischemia times (MD 4.40 [95% CI 3.72-5.08], P < .00001, I<sup>2</sup> = 0%), hypertension (RR 1.07 [1.03-1.11], P = .0006, I<sup>2</sup> = 0%), diabetes (RR 1.16 [1.04-1.29], P = .007, I<sup>2</sup> = 24%), ischemic heart disease (RR 1.51 [1.26-1.82], P < .00001, I<sup>2</sup> = 0%), systolic blood pressure (MD 10.98 [9.44-12.51], P < .00001, I<sup>2</sup> = 0%), diastolic blood pressure (MD 7.64 [2.30-12.97], P = .005, I<sup>2</sup> = 85%), delayed graft function (OR 2.11 [1.31-3.38], P = .002, I<sup>2</sup> = 58%), and acute rejection (RR 1.84 [1.24-2.71], P = .002, I<sup>2</sup> = 0%).</p><p><strong>Conclusions: </strong>Multiple variables have been identified as risk factors for TRAS. Since TRAS is linked to allograft dysfunction and poorer outcomes, effectively managing and improving these factors could result in better long-term results for kidney transplant recipients.</p>\",\"PeriodicalId\":94258,\"journal\":{\"name\":\"Transplantation proceedings\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplantation proceedings\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.transproceed.2025.08.017\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.transproceed.2025.08.017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:移植肾动脉狭窄(TRAS)是一种典型的血管并发症,占肾移植术后血管事件的75%。移植后并发症如同种异体移植物功能障碍、同种异体移植物丧失和移植后高血压均归因于TRAS。本研究旨在评价肾移植术后TRAS发生的相关危险因素。方法:对Science Direct和PubMed数据库中从成立到2024年1月发表的研究进行荟萃分析。评估肾移植后TRAS患病率和评估其危险因素的出版物被纳入研究。结果:共纳入16篇文献。43446例患者中TRAS发生率为1465例(3.37%)。研究了与肾移植后TRAS发生有关的几个变量。tra利用的相关变量发展多个同种异体移植物动脉(或3.08 (95% CI 1.30 - -7.28), P = . 01, I2 = 33%),冷缺血时间(MD 4.40 (95% CI 3.72 - -5.08), P < .00001 I2 = 0%)、高血压(RR 1.07 (1.03 - -1.11), P =考虑,I2 = 0%)、糖尿病(RR 1.16 (1.04 - -1.29), P = .007, I2 = 24%),缺血性心脏病(RR 1.51 [1.26 - -1.82], P < .00001 I2 = 0%)、收缩压(MD 10.98 [9.44 - -12.51], P < .00001 I2 = 0%)、舒张压(MD 7.64 (2.30 - -12.97),P = 0.005, I2 = 85%)、延迟移植功能(OR 2.11 [1.31-3.38], P = 0.002, I2 = 58%)和急性排斥反应(RR 1.84 [1.24-2.71], P = 0.002, I2 = 0%)。结论:多个变量被确定为TRAS的危险因素。由于TRAS与同种异体移植物功能障碍和较差的预后有关,有效地管理和改善这些因素可以为肾移植受者带来更好的长期结果。
Risk Factors of Transplant Renal Artery Stenosis: A Meta-analysis.
Background: Transplant renal artery stenosis (TRAS) is a typical vascular complication that accounts for 75% of all vascular events following kidney transplantation. Post-transplant complications such as allograft dysfunction, allograft loss, and post-transplant hypertension have been attributed to TRAS. This study aims to evaluate the risk factors related to TRAS after kidney transplantation.
Methods: A meta-analysis of studies that were published from inception until January 2024 was accomplished from the Science Direct and PubMed databases. Publications evaluating the prevalence of TRAS after kidney transplantation and assessing its risk factors were included in the study.
Results: Sixteen publications were included in the study. The incidence of TRAS was 1465 cases (3.37%) from 43,446 patients. Several variables relating to the occurrence of TRAS after kidney transplantation were examined. The variables that related to the development of TRAS were multiple allograft arteries (OR 3.08 [95% CI 1.30-7.28], P = .01, I2 = 33%), cold ischemia times (MD 4.40 [95% CI 3.72-5.08], P < .00001, I2 = 0%), hypertension (RR 1.07 [1.03-1.11], P = .0006, I2 = 0%), diabetes (RR 1.16 [1.04-1.29], P = .007, I2 = 24%), ischemic heart disease (RR 1.51 [1.26-1.82], P < .00001, I2 = 0%), systolic blood pressure (MD 10.98 [9.44-12.51], P < .00001, I2 = 0%), diastolic blood pressure (MD 7.64 [2.30-12.97], P = .005, I2 = 85%), delayed graft function (OR 2.11 [1.31-3.38], P = .002, I2 = 58%), and acute rejection (RR 1.84 [1.24-2.71], P = .002, I2 = 0%).
Conclusions: Multiple variables have been identified as risk factors for TRAS. Since TRAS is linked to allograft dysfunction and poorer outcomes, effectively managing and improving these factors could result in better long-term results for kidney transplant recipients.